JNPR
65
2
DVA
61
2
NDAQ
70
4
AVY
47
-4
KMI
57
2
APA
34
2
DHR
49
2
BBY
48
3
FE
69
2
KR
65
-3
AES
32
-2
PPL
82
-2
OI
49
2
MSI
60
3
BIIB
36
-9
VIX
54
-9
LUV
42
-6
CSCO
64
13
KEY
48
-12
TRIP
47
3
JNPR
65
2
DVA
61
2
NDAQ
70
4
AVY
47
-4
KMI
57
2
APA
34
2
DHR
49
2
BBY
48
3
FE
69
2
KR
65
-3
AES
32
-2
PPL
82
-2
OI
49
2
MSI
60
3
BIIB
36
-9
VIX
54
-9
LUV
42
-6
CSCO
64
13
KEY
48
-12
TRIP
47
3
Financhill
Back

Kaival Brands Innovations Group Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Sell
23

KAVL
Kaival Brands Innovations Group

Last Price:
$0.49
Seasonality Move:
252.62%
Buy
63

RYTM
Rhythm Pharmaceuticals

Last Price:
$63.69
Seasonality Move:
15.42%
Sell
23
Kaival Brands Innovations Group (KAVL) is a Sell

Is Kaival Brands Innovations Group a Buy, Sell or Hold?

  • The current Kaival Brands Innovations Group [KAVL] share price is $0.50. The Score for KAVL is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • KAVL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $63.76. The Score for RYTM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KAVL Stock Price Chart

What is Kaival Brands Innovations Group's stock price today?

  • The Kaival Brands Innovations Group share price today is $0.50
    The current trend is relatively stagnant and KAVL is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $63.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.

KAVL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 39.01 Sell
Chaikin Money Flow: 29435 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.48 - 0.56) Sell
Bollinger Bands (100): (0.56 - 1.12) Sell

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.28 Buy
Relative Strength Index (14 RSI): 63.66 Buy
Chaikin Money Flow: 369446 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.02 - 61.16) Buy
Bollinger Bands (100): (53.03 - 59.91) Buy

KAVL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.49 Buy
20-day SMA: 0.51 Sell
50-day SMA: 0.65 Sell
200-day SMA: 0.87 Sell
8-day EMA: 0.49 Buy
20-day EMA: 0.52 Sell
50-day EMA: 0.65 Sell
200-day EMA: 1.38 Sell

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.43 Buy
20-day SMA: 57.42 Buy
50-day SMA: 55.27 Buy
200-day SMA: 53.46 Buy
8-day EMA: 61.16 Buy
20-day EMA: 58.64 Buy
50-day EMA: 56.64 Buy
200-day EMA: 52.62 Buy

Kaival Brands Innovations Group Earnings Growth & KAVL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.

Kaival Brands Innovations Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):